The Lancet Gastroenterology & Hepatology in conversation with
A podcast by The Lancet Group
88 Episodes
-
Tim Vanuytsel on spore-forming probiotics in functional dyspepsia
Published: 09/09/2021 -
Raymond Henderson on the economic burden of colorectal cancer
Published: 12/08/2021 -
Sigurður Ólafsson on eliminating hepatitis C in Iceland
Published: 22/06/2021 -
Caroline Ovadia on intrahepatic cholestasis of pregnancy
Published: 03/06/2021 -
Matthew Akiyama on hepatitis C in prisons
Published: 12/04/2021 -
Monika Sarkar on reproductive health in women with liver disease
Published: 11/03/2021 -
Colorectal cancer risk in patients with Crohn’s disease
Published: 12/03/2020 -
Liver damage in young adults
Published: 17/01/2020 -
Treatments for IBS
Published: 14/01/2020 -
Statins and decompensated cirrhosis
Published: 27/11/2019 -
Global burden of pancreatic cancer and colorectal cancer
Published: 04/11/2019 -
Paediatric inflammatory bowel disease
Published: 12/09/2019 -
Transplanting hepatitis C-infected hearts
Published: 28/08/2019 -
Primary anastomosis as a treatment for diverticulitis
Published: 31/07/2019 -
Faecal microbiota transplantation in IBS
Published: 30/07/2019 -
Treating faecal incontinence in women
Published: 17/07/2019 -
Viral hepatitis in children & adolescents
Published: 23/05/2019 -
Whole-body MRI: the STREAMLINE trials
Published: 11/05/2019 -
A new drug for short bowel syndrome
Published: 05/04/2019 -
Eosinophilic oesophagitis endotype classification
Published: 09/03/2019
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
